These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3432434)

  • 21. Global-local visual processing in schizophrenia: evidence for an early visual processing deficit.
    Johnson SC; Lowery N; Kohler C; Turetsky BI
    Biol Psychiatry; 2005 Dec; 58(12):937-46. PubMed ID: 16084856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing.
    Gallinat J; Winterer G; Herrmann CS; Senkowski D
    Clin Neurophysiol; 2004 Aug; 115(8):1863-74. PubMed ID: 15261865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia.
    Surguladze S; Russell T; Kucharska-Pietura K; Travis MJ; Giampietro V; David AS; Phillips ML
    Biol Psychiatry; 2006 Sep; 60(5):423-31. PubMed ID: 16487943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cortical processing of visual and auditory stimuli in depressive patients: a study with event related potentials].
    Ortiz T; Pérez-Serrano JM; Coullaut J; Fudio S; Coullaut J; Criado J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(4):215-21. PubMed ID: 9807854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia.
    Umbricht DS; Bates JA; Lieberman JA; Kane JM; Javitt DC
    Biol Psychiatry; 2006 Apr; 59(8):762-72. PubMed ID: 16497277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between somatosensory and auditory cognitive processing assessed with event-related potentials.
    Touge T; Gonzalez D; Wu J; Deguchi K; Tsukaguchi M; Shimamura M; Ikeda K; Kuriyama S
    J Clin Neurophysiol; 2008 Apr; 25(2):90-7. PubMed ID: 18340272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of auditory and visual attention in schizophrenia.
    Wood SM; Potts GF; Martin LE; Kothmann D; Hall JF; Ulanday JB
    Psychiatry Res; 2007 Nov; 156(2):105-16. PubMed ID: 17889512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative study of evoked potentials on clinical symptoms and treatment efficiency in acute schizophrenics].
    Zhang MD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Jun; 21(3):178-82, 190. PubMed ID: 3229210
    [No Abstract]   [Full Text] [Related]  

  • 29. Steady state visually evoked potential correlates of auditory hallucinations in schizophrenia.
    Line P; Silberstein RB; Wright JJ; Copolov DL
    Neuroimage; 1998 Nov; 8(4):370-6. PubMed ID: 9811555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The P300 metric in schizophrenia: effects of probability and modality.
    Duncan CC; Perlstein WM; Morihisa JM
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 40():670-4. PubMed ID: 2891497
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of evoked potentials in psychiatry. III. Evoked potentials and prediction of the effectiveness of psychopharmaceuticals].
    Chaloupková L; Komzák F; Kolomazník M; Seidl J; Hronek J; Sefrna F
    Cesk Psychiatr; 1988 Aug; 84(4):217-22. PubMed ID: 3180280
    [No Abstract]   [Full Text] [Related]  

  • 32. [A method of evoked potentials in the study of cognitive processes in schizophrenia].
    Alfimova MV; Uvarova LG; Trubnikov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(1):62-8. PubMed ID: 11530465
    [No Abstract]   [Full Text] [Related]  

  • 33. State-trait considerations of event-related potential markers of psychopathology.
    Pfefferbaum A; Roth WT; Kopell BS
    Psychopharmacol Bull; 1979 Jan; 15(1):36-9. PubMed ID: 419247
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of opioid peptides in disorders of attention in psychopathology.
    Buchsbaum MS; Reus VI; Davis GC; Holcomb HH; Cappelletti J; Silberman E
    Ann N Y Acad Sci; 1982; 398():352-65. PubMed ID: 6297359
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial and sporadic schizophrenia: visual evoked potential differences.
    Schwarzkopf SB; Chapman RM; Jimenez M; Treglia L; Kane CF; Lamberti JS; Nasrallah HA
    Biol Psychiatry; 1988 Nov; 24(7):828-33. PubMed ID: 3228568
    [No Abstract]   [Full Text] [Related]  

  • 36. Cortical augmenting-reducing--modality specific?
    Raine A; Mitchell DA; Venables PH
    Psychophysiology; 1981 Nov; 18(6):700-8. PubMed ID: 7313029
    [No Abstract]   [Full Text] [Related]  

  • 37. Normalization of auditory brainstem responses resulting from improved clinical symptoms in schizophrenia.
    Igata M; Ohta M; Hayashida Y; Abe K
    Schizophr Res; 1995 Jul; 16(1):81-2. PubMed ID: 7547650
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurophysiological study of schizophrenia: an abnormality of P3s.
    Saitoh O
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):89-93. PubMed ID: 1882593
    [No Abstract]   [Full Text] [Related]  

  • 39. P3 and CT scan in patients with chronic schizophrenia.
    Ebmeier K; Potter D; Salzen E
    Br J Psychiatry; 1988 Feb; 152():290-2. PubMed ID: 3167354
    [No Abstract]   [Full Text] [Related]  

  • 40. P3 and CT scan in patients with chronic schizophrenia.
    Barrett K; McCallum WC; Pocock PV
    Br J Psychiatry; 1988 Aug; 153():263. PubMed ID: 3255448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.